发明名称 Retinal derivatives and methods for the use thereof for the treatment of visual disorders
摘要 Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided.
申请公布号 US9174936(B2) 申请公布日期 2015.11.03
申请号 US201113042308 申请日期 2011.03.07
申请人 University of Washington 发明人 Palczewski Krzysztof;Batten Matthew
分类号 A61K31/225;A61K31/20;C07C403/14;C07C403/10;C07C403/12;C07C403/20;A61K31/22;A61K31/215 主分类号 A61K31/225
代理机构 McDermott Will & Emery LLP 代理人 Mahoney Jacqueline F.;Mohr Judy M.;McDermott Will & Emery LLP
主权项 1. A method for treatment of an endogenous 11-cis-retinal deficiency in an eye of a human subject, the method comprising: administering to the human subject in need thereof a therapeutically effective amount of a synthetic retinyl ester that is a 9-cis-retinyl ester or an 11-cis-retinyl ester, wherein the 9-cis-retinyl ester has a structure as represented by Formula I or the 11-cis-retinyl ester has a structure as represented by Formula II, wherein A in each formula is CH2OR and R forms a retinyl ester, and the ester substituent of said retinyl ester comprises a carboxylate radical of a C1 to C10 monocarboxylic acid or a C2 to C22 polycarboxylic acid: wherein the ester substituent is selected from the group consisting of formate, acetate, propionate, butyrate, valerate, caproate, heptanoate, caprylate, pelargonate, caprate, oxalate, malonate, succinate, fumarate, malate, glutarate, adipate, pimelate, suberate, azelate, sebacate, citrate, oxaloacetate, and ketoglutarate.
地址 Seattle WA US